P. Clavère

1.8k total citations · 1 hit paper
45 papers, 1.2k citations indexed

About

P. Clavère is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, P. Clavère has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in P. Clavère's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers) and Colorectal Cancer Surgical Treatments (6 papers). P. Clavère is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers) and Colorectal Cancer Surgical Treatments (6 papers). P. Clavère collaborates with scholars based in France, Israel and Serbia. P. Clavère's co-authors include P. Maingon, M. Bolla, René‐Jean Bensadoun, J. Giralt, Suzana Stojanović-Rundić, É. Bardet, Jean-Claude Ollier, Alexander Beny, G. Calais and Jean‐Luc Van Laethem and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

P. Clavère

39 papers receiving 1.1k citations

Hit Papers

Fluorouracil-based adjuva... 2014 2026 2018 2022 2014 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P. Clavère 807 481 218 199 154 45 1.2k
I. Benjamin Paz 607 0.8× 677 1.4× 251 1.2× 189 0.9× 238 1.5× 48 1.4k
Yufan Cheng 385 0.5× 326 0.7× 210 1.0× 169 0.8× 120 0.8× 51 949
Asawari Patil 380 0.5× 284 0.6× 224 1.0× 151 0.8× 77 0.5× 88 927
TG Cooke 450 0.6× 238 0.5× 146 0.7× 185 0.9× 76 0.5× 35 883
Martin Hyrcza 528 0.7× 626 1.3× 113 0.5× 127 0.6× 115 0.7× 46 1.2k
Fredrik Enlund 555 0.7× 444 0.9× 231 1.1× 74 0.4× 61 0.4× 31 1.4k
Fausto Maffini 658 0.8× 616 1.3× 389 1.8× 581 2.9× 165 1.1× 71 1.6k
Juan C. Hernandez‐Prera 452 0.6× 588 1.2× 137 0.6× 141 0.7× 158 1.0× 70 1.3k
Sue A. Bartow 406 0.5× 279 0.6× 248 1.1× 330 1.7× 56 0.4× 25 1.1k
Lourdes R. Ylagan 492 0.6× 485 1.0× 289 1.3× 107 0.5× 159 1.0× 40 1.1k

Countries citing papers authored by P. Clavère

Since Specialization
Citations

This map shows the geographic impact of P. Clavère's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Clavère with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Clavère more than expected).

Fields of papers citing papers by P. Clavère

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Clavère. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Clavère. The network helps show where P. Clavère may publish in the future.

Co-authorship network of co-authors of P. Clavère

This figure shows the co-authorship network connecting the top 25 collaborators of P. Clavère. A scholar is included among the top collaborators of P. Clavère based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Clavère. P. Clavère is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bourgier, C., Émilie Bayart, J. Chamois, et al.. (2023). Métier de manipulateur en radiothérapie en tension en France : conséquences organisationnelles et difficultés à déployer de nouvelles missions et/ou délégation de tâches. Cancer/Radiothérapie. 27(6-7). 577–582. 1 indexed citations
3.
Bayart, Émilie, et al.. (2023). Enquête SFRO–SNRO–AFPPE sur l’évolution du métier de manipulateur exerçant en radiothérapie en France. Cancer/Radiothérapie. 27(8). 712–717. 1 indexed citations
4.
Hennequin, Christophe, E. Rio, L. Quéro, & P. Clavère. (2021). Radiation therapy of cutaneous cancers. Cancer/Radiothérapie. 26(1-2). 397–403. 6 indexed citations
5.
Biau, J., et al.. (2021). Facteurs prédictifs de l’ostéoradionécrose mandibulaire après irradiation des cancers des voies aérodigestives supérieures. Cancer/Radiothérapie. 25(5). 484–493. 7 indexed citations
7.
Schlienger, M., et al.. (2019). Effets de l’irradiation à haute dose sur la vascularisation : physiopathologie et conséquences cliniques. Cancer/Radiothérapie. 23(2). 161–167. 11 indexed citations
8.
Bosset, Jean-François, G. Calais, Laurent Mineur, et al.. (2014). Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. The Lancet Oncology. 15(2). 184–190. 505 indexed citations breakdown →
9.
Deluche, Élise, et al.. (2014). Two Cases of Cutaneous Drug Eruption Associated with Temozolomide Therapy for Glioblastoma. Current Oncology. 21(6). 779–781. 5 indexed citations
10.
Bonerandi, J. J., Céline Beauvillain, V. Chaussade, et al.. (2011). Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. Journal of the European Academy of Dermatology and Venereology. 25(s5). 1–51. 117 indexed citations
11.
Carrié, C., Jacques Grill, Dominique Figarella‐Branger, et al.. (2009). Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98. Journal of Clinical Oncology. 27(11). 1879–1883. 49 indexed citations
12.
Trouillas, Patrick, et al.. (2009). Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies. Supportive Care in Cancer. 19(1). 57–65. 18 indexed citations
13.
Clavère, P., et al.. (2008). Réactions cutanées induites par la radiothérapie. Annales de Dermatologie et de Vénéréologie. 135(1). 1–4. 20 indexed citations
14.
Kerbrat, Pierre, Henri Roché, Jacques Bonneterre, et al.. (2007). Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial. British Journal of Cancer. 96(11). 1633–1638. 11 indexed citations
15.
Genet, Dominique, C Lejeune, Pascal Bonnier, et al.. (2007). Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up. British Journal of Cancer. 97(7). 883–887. 19 indexed citations
17.
Veyret, Corinne, Christelle Lévy, P. Chollet, et al.. (2006). Inflammatory breast cancer outcome with epirubicin‐based induction and maintenance chemotherapy. Cancer. 107(11). 2535–2544. 27 indexed citations
18.
Clavère, P., et al.. (1997). Postoperative Interstitial Radiotherapy of Keloids by Iridium 192: A Retrospective Study of 46 Treated Scars. Dermatology. 195(4). 349–352. 34 indexed citations
19.
Meur, Yannick Le, C. Bédane, P. Clavère, P. Peyronnet, & C. Leroux‐Robert. (1997). A proliferative vascular tumour of the skin in a kidney-transplant recipient (recurrent pyogenic granuloma with satellitosis). Nephrology Dialysis Transplantation. 12(6). 1271–1273. 6 indexed citations
20.
Roullet, Bernard, M Labadie, Henryk Taper, et al.. (1990). Valeur prédictive des variations de l'activité sérique de la DNAse alcaline dans le pronostic des cancers des voies aérodigestives supérieures traités par chimiothérapie.. Bulletin du Cancer. 77(7). 675–680. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026